Sequential antibiotic therapy: Effective cost management and patient care (Q35893020)

11 August 2017

Sequential antibiotic therapy: Effective cost management and patient care (English)

1 reference

11 August 2017

1 reference

L A Mandell

1

1 reference

11 August 2017

M G Bergeron

2

1 reference

11 August 2017

M J Gribble

3

1 reference

11 August 2017

P J Jewesson

4

1 reference

11 August 2017

D E Low

5

1 reference

11 August 2017

T J Marrie

6

1 reference

11 August 2017

L E Nicolle

7

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 November 1995

1 reference

Canadian Journal of Infectious Diseases & Medical Microbiology

11 August 2017

1 reference

11 August 2017

6

1 reference

11 August 2017

6

1 reference

11 August 2017

306-315

1 reference

Creative Commons Attribution 4.0 International

11 August 2017

start time

1 January 1995

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Guidelines for antimicrobial utilization in health care facilities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Cost-effectiveness and value of an IV switch

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Economic impact of streamlining antibiotic administration

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Sequential intravenous-oral amoxycillin/clavulanate (Augmentin) therapy in paediatric hospital practice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Treatment of serious infections with intravenous ciprofloxacin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Use of intravenous ciprofloxacin in difficult-to-treat infections.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Antibiotic Streamlining From Combination Therapy to Monotherapy Utilizing an Interdisciplinary Approach

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

New era for orally administered antibiotics: use of sequential parenteral-oral antibiotic therapy for serious infectious diseases of infants and children

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Experience with parenteral and sequential parenteral-oral amoxicillin/clavulanate (augmentin) in hospitalized patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Pharmacokinetics of ciprofloxacin after oral and parenteral administration

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

How often is medication taken as prescribed? A novel assessment technique

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Prospective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infections

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Intravenous/oral ciprofloxacin therapy versus intravenous ceftazidime therapy for selected bacterial infections

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Intravenous and sequential intravenous and oral ciprofloxacin in the treatment of severe infections

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Ciprofloxacin in patients with bacteremic infections. The Spanish Group for the Study of Ciprofloxacin.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

A comparative study of ofloxacin and amoxycillin/clavulanate in hospitalized patients with lower respiratory tract infections.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Cost comparison of intravenous antibiotic administration

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Antimicrobial formulary management: meeting the challenge in the community hospital

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Therapy for women hospitalized with acute pyelonephritis: a randomized trial of ampicillin versus trimethoprim-sulfamethoxazole for 14 days.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Strategic antibiotic decision-making at the formulary level

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

High-pressure liquid chromatography and microbiological assay of serum ofloxacin levels in adults receiving intravenous and oral therapy for skin infections

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Microbial etiology of urban emergency department acute salpingitis: treatment with ofloxacin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Intravenous-to-oral stepdown program: four years of experience in a large teaching hospital

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Clindamycin treatment of osteomyelitis and septic arthritis in children

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

High-dose oral dicloxacillin treatment of acute staphylococcal osteomyelitis in children

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Use of the serum bactericidal titer to assess theadequacy of oral antibiotic therapy in the treatment of acute hematogenous osteomyelitis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Prescribing considerations in fluoroquinolone therapy.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

A sequential study of intravenous and oral fleroxacin in the treatment of complicated urinary tract infection.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Sequential intravenous/oral ciprofloxacin in the treatment of severe multiresistant gram-negative infections.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Sequential intravenous and oral ciprofloxacin versus intravenous ceftazidime in the treatment of complicated urinary tract infections

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Intravenous/oral ciprofloxacin therapy of infections caused by multiresistant bacteria.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327940

Simple ways to promote cost containment

24 September 2018

1 reference

12 December 2020

Pharmacokinetic considerations in quinolone therapy

1 reference

12 December 2020

Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections

1 reference

12 December 2020

Comparative evaluation of the aminopenicillins for oral use

1 reference

12 December 2020

Randomized study of intravenous versus sequential intravenous/oral regimen of ciprofloxacin in the treatment of gram-negative septicemia

1 reference

12 December 2020

Benefits and risks of sequential parenteral--oral cephalosporin therapy for suppurative bone and joint infections

1 reference

12 December 2020

Sequential therapy with I. V. and oral ofloxacin in lower respiratory tract infections: A comparative study

1 reference

12 December 2020

Clinical experiences with ofloxacin sequential therapy in chronic ear infections

1 reference

12 December 2020

Pharmacokinetic comparison of intravenous and oral chloramphenicol in patients with Haemophilus influenzae meningitis

1 reference

12 December 2020

Intravenous ciprofloxacin

1 reference

12 December 2020

Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections

1 reference

12 December 2020

Oral antibiotic therapy for skeletal infections of children. II. Therapy of osteomyelitis and suppurative arthritis

1 reference

12 December 2020

Parenteral Followed by Oral Ofloxacin for Nosocomial Pneumonia and Community-acquired Pneumonia Requiring Hospitalization

1 reference

12 December 2020

How to read clinical journals: V: To distinguish useful from useless or even harmful therapy

1 reference

12 December 2020

Therapy of serious skin and soft tissue infections with ofloxacin administered by intravenous and oral route

1 reference

12 December 2020

Clinical and economic impact of oral ciprofloxacin as follow-up to parenteral antibiotics

1 reference

12 December 2020

Twelve-hourly dosage schedule for oral and intravenous metronidazole

1 reference

12 December 2020

Sequential intravenous/oral therapy with ciprofloxacin in severe infection

1 reference

12 December 2020

Ciprofloxacin versus a tobramycin/cefuroxime combination in the treatment of serious systemic infections: a prospective, randomized and controlled study of efficacy and safety

1 reference

12 December 2020

Staphylococcal osteomyelitis in children. Success with cephaloridine-cephalexin therapy

1 reference

12 December 2020

Prospective, controlled, randomized non-blind comparison of intravenous/oral ciprofloxacin with intravenous ceftazidime in the treatment of skin or soft-tissue infections

1 reference

12 December 2020

Sequential intravenous/oral ciprofloxacin compared with intravenous ceftazidime in the treatment of serious lower respiratory tract infections

1 reference

12 December 2020

Antimicrobial formulary management: a case study in a teaching hospital

1 reference

12 December 2020

Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule

1 reference

12 December 2020

Identifiers

DOI

10.1155/1995/165848

1 reference

11 August 2017

1 reference

11 August 2017

1 reference